BTG recoils at rattlesnake roundup 'gassing'

Photo courtesy of Tambako the Jaguar, Creative Commons BY-ND 2.0

A British drugmaker has landed in the middle of the controversy over Sweetwater, Texas' Rattlesnake RoundUp. State wildlife officials want to ban the event, which each year draws more than 40,000 people ready to smoke snakes out of their dens with fumes, the Financial Times reports. But hunters claim the practice helps provide venom to BTG, which makes the only U.S.-approved antidote for rattlesnake bites. The company, which sold about £63 million ($104.7 million) worth of the antidote last year, says it actually favors the ban on "gassing" and that it can get most of the venom it needs to manufacture CroFab from its own snake farm in Utah. Story (sub. req.)

Suggested Articles

The CD19 antibody, used in tandem with Celgene's Revlimid, represents the first FDA approval in second-line diffuse large B-cell lymphoma.

Sanofi has faced a probe into birth defects tied to seizure med Depakine for years. Now, the investigation is moving forward on manslaughter charges.

Pfizer launched a multichannel awareness campaign centered on a first-ever radio station dedicated solely to metastatic breast cancer.